Suppression, subversion and escape: the role of regulatory T cells in cancer progression - Wikidata - awgldk - TriplyDB

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

http://www.wikidata.org/entity/Q27026151

about

Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.T cell receptor mimic antibodies for cancer therapy Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer Metastatic mechanisms in follicular cell-derived thyroid cancer The immunoregulatory role of type I and type II NKT cells in cancer and other diseases Trends and advances in tumor immunology and lung cancer immunotherapy The role of integrins in TGFβ activation in the tumour stroma Pim-1 kinase as cancer drug target: An update TFPI1 mediates resistance to doxorubicin in breast cancer cells by inducing a hypoxic-like response T Cells Deficient in the Tyrosine Phosphatase SHP-1 Resist Suppression by Regulatory T Cells.Antitumor activity of total flavonoids from Tetrastigma hemsleyanum Diels et Gilg is associated with the inhibition of regulatory T cells in mice.Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis.Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responses Inflammasome activation is critical to the protective immune response during chemically induced squamous cell carcinoma.Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers.Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).Mechanisms and applications of interleukins in cancer immunotherapy.CD8(+)/FOXP3(+)-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.Forkhead-box transcription factor 1 affects the apoptosis of natural regulatory T cells by controlling Aven expression.Ionizing radiation, ion transports, and radioresistance of cancer cells Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma.Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy.Location of tumor affects local and distant immune cell type and number Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea.Natural and induced T regulatory cells in cancer.Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.Cellular prognostic markers in hepatocellular carcinoma.Increased regulatory T cells in acute lymphoblastic leukemia patients.Hepatic myeloid-derived suppressor cells in cancer.Increased regulatory T cells in acute lymphoblastic leukaemia patients.Inhibition of mouse breast adenocarcinoma growth by ablation with intratumoral alpha-irradiation combined with inhibitors of immunosuppression and CpG.Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives.Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities.Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells.Surface Antigen Profiling of Helicobacter pylori-Infected and -Uninfected Gastric Cancer Cells Using Antibody Microarray.Emerging nanotechnologies for cancer immunotherapy

P2860

Q26744624-35FEAE79-E200-499F-9AE0-5C8C08C817AF Q26768271-F2552FB4-E69C-4191-9F56-41E542462DDB Q26996829-F94B9F5F-81B5-430B-98B1-7D3DB2BAC3FB Q27005646-572E8873-6580-4AC8-8290-6B178EA6E5B8 Q27027556-C746120D-E4D2-4F86-B384-6D0D562D7A35 Q28067674-0B6D326F-88EE-4947-8C2C-779C92DBDBBA Q28068373-934AADE8-CBC1-4F35-A22B-5B942EF0EDD8 Q28273475-4343335D-C4A6-4A01-BD3A-849EDEE9E92F Q28539226-93885E50-0E5B-4C46-854C-CC861447DB6D Q30252330-1B470A1B-B62C-4DBE-9973-347568E0F299 Q33769458-87E2A081-787C-43B7-B5A8-17046682CE5C Q33779401-D244A8CF-0B4C-47EE-9E1B-06AE8C0DCC9A Q33889323-3983DF64-912A-45F3-B228-98E4955D935B Q34041661-745EC9CC-B86A-4759-B26A-1CA18C6F788F Q34135426-50A6CF8A-1BFB-4DEF-A51C-BA8A9222B5EF Q34275796-7084AA8D-2AD3-47F8-B28C-1BB5D2197A14 Q34445730-3FBBC934-6419-43DD-BE7F-76DD4BD61A73 Q34446934-F836A7FD-D509-4423-94BB-850737214F73 Q34458290-39592C0B-0CD0-4531-8951-01F50407CA55 Q35506606-C02EDF02-2D4E-48FA-9699-C06836CB2957 Q36085104-F744FCC7-11DC-43DE-8839-79B49D7F52A7 Q36304690-6215BAEA-549C-44F1-8773-7F6E75F3BDF9 Q37095176-1E355E82-0F9E-4B85-B776-42C8FDB67FA0 Q37432037-79166327-D78E-461B-994C-B1CF11DA0FEB Q37483915-8DB9240D-1984-432D-A018-B3832EC6D4F8 Q37520816-7B731584-D408-483F-8206-4D68FC8C3D03 Q37660747-45FD3E98-E339-44DB-A90E-F75BD0E1D6BA Q37688491-6B4FED02-DB2D-4429-8D96-643615BA0F8D Q38123165-123481C5-720D-460F-A01E-93A61AEEB013 Q38185156-C35DEC9F-821C-4690-867A-D635AFA21A74 Q38515812-D13CFD69-0F08-456D-B0B9-0A1736BDEBA9 Q38539663-EBE9AE5D-8226-45FD-A67B-ED5FF3443FC0 Q38541582-CCE5EC50-5E86-4BFE-B94D-47C8FD475303 Q38747439-0272B037-DFDF-4A3B-9BF3-99C6A9EB76A7 Q38753622-B4E2EBB9-33A3-4B08-A204-B49F9C8C744F Q38756298-CC6D01AB-34F2-4B27-A7CC-897511AFB898 Q38770814-BAD4C50F-B39C-48DB-9B3D-5B018D78C04B Q38787449-C3CD9CDD-B9FD-43DA-9EE3-AC5597EF152C Q38799687-9DE37004-8F8C-43DD-AC3C-1E5020BBBC95 Q38837036-3035DEF8-0B8E-4887-B01C-E87B89F80B6B

P2860

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

http://www.wikidata.org/entity/Q27026151

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

@ast

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

@en

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

@nl

type

label

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

@ast

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

@en

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

@nl

prefLabel

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

@ast

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

@en

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

@nl

P1433

Q27026151-F6AEA931-32D8-4DBF-AF79-24889B81D538

P1476

Q27026151-01E5780B-DDF9-4F3D-A6C4-9626C3E7FA26

P2093

Q27026151-42902393-EC9A-4864-B31D-9B4BE9C8CE48

Q27026151-D3CCCAD3-A6D1-466A-AD32-ADD6FB5D3888

P2860

Q27026151-0217B559-E3DE-445B-8FD3-CB4A1681FEA1

Q27026151-09DD53E9-E354-440B-99A6-88C6892A3FB2

Q27026151-0B0E6C0E-290B-43AE-AA37-0395F1C0CA27

Q27026151-0BD53931-F7D9-44D6-9CC5-CD07EB1972B4

Q27026151-0E89D56A-05B3-47D3-9F76-285A21FF08BD

Q27026151-0F3EAC0E-9E9E-4CC4-A0B5-161B2AACA175

Q27026151-10FF20E8-53FE-4040-918A-602DCD527EB0

Q27026151-1307F307-B25E-4FA5-9364-DE3562F2BDD1

Q27026151-153A2739-5FEC-4FE0-B431-3AC54D062311

Q27026151-17B101C7-F3A7-46B9-AFD3-22490E35123B

P304

Q27026151-B6B27067-886D-4834-A2FF-4403AEB5CE7B

P31

Q27026151-0903ff71-040d-4491-aa95-d7971d51d2d8

Q27026151-78879122-0E7E-4FCB-8E72-F7AAEBF60C15

P3181

Q27026151-D1E9F311-6C4C-46C3-ACE8-25D78C7460E5

P356

Q27026151-3AB23E4C-3E3D-458A-995C-7B330D57953D

P407

Q27026151-AF435CE6-DCD4-4C37-9B19-BDEC33995145

P433

Q27026151-9AF06575-D133-4C37-BB57-ADCAA0185258

P478

Q27026151-CFC26D07-8BC0-47CA-BA81-A50B0FC79F39

P50

Q27026151-46ACA092-912B-4061-828B-CBF6701FF9AA

Q27026151-A4F342A0-EFC5-4BC4-AE55-9361210E8FD8

P577

Q27026151-8EEEF655-B10F-4792-ACFD-A3A018A26913

P5875

Q27026151-B05539E5-C86F-45C7-890A-BA205CE4179F

P698

Q27026151-C51CA7D1-48A3-4CAF-A224-F5373D8C82E2

P932

Q27026151-2ACD12B5-8CB4-491C-9942-CCBC8ABFF4B0

P3181

P356

J.1365-2249.2012.04657.X

P1433

Clinical and Experimental Immunology

P1476

Suppression, subversion and escape: the role of regulatory T cells in cancer progression

@en

P2093

A R Fraser

http://www.w3.org/2001/XMLSchema#string

K Oleinika

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

Hallmarks of Cancer: The Next Generation

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

P304

36-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1545075

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1365-2249.2012.04657.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P50

Gerard J Graham

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233825673

http://www.w3.org/2001/XMLSchema#string

P698

23199321

http://www.w3.org/2001/XMLSchema#string

P932

3530093

http://www.w3.org/2001/XMLSchema#string